WAYNE, Pa. — Facet Life Sciences has appointed Frank A. Closurdo as vice president of commercial services, expanding the company’s integrated regulatory and commercial advisory capabilities for biotechnology and pharmaceutical clients.
The Wayne-based company said Closurdo brings more than 20 years of experience across biopharmaceuticals, medical devices and healthcare marketing. His background includes leadership roles at global organizations and early-stage companies, with experience developing commercial strategies and supporting product launches, acquisitions and licensing efforts in regulated healthcare markets.
“I am thrilled to have a seasoned professional like Frank join the Facet team,” said Ken VanLuvanee, Facet’s CEO & Board Chairman. “His years of successful consulting, deep understanding of how to turn a scientific concept into a market product, and familiarity with the needs of emerging life sciences companies, Facet’s core constituency, will be a huge win for our clients.”
Facet said Closurdo will focus on bringing commercial strategy earlier into the development process to help maximize product value and support patient outcomes. He will work with the company’s regulatory strategy experts to align clinical protocols, regulatory expectations and market considerations from the beginning of development.
The company said the appointment strengthens its role as a partner for lean life sciences teams seeking both regulatory success and commercial viability in an increasingly complex healthcare market.
